Molecular Diagnostics Market: By Technology (Polymerase chain reaction, Microarray, Next-generation sequencing, Isothermal nucleic acid amplification, Hybridization, Others), By Application (Caner, Blood screening, Infectious diseases, Microbiology, Genetic tests, Others), By End User (Hospitals, Diagnostic Centres, Research institutes, Others), and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Molecular Diagnostics Market size was valued at USD 9,682.4 million in 2022, and growing at a CAGR of 10.1% from 2023 to 2029. The global market provides a detailed overview that can be segmented by technology, by application, and by end user. By technology, the global molecular diagnostics market has been segmented into Polymerase chain reaction, Microarray, Next-generation sequencing, Isothermal nucleic acid amplification, Hybridization, and Others. The Polymerase chain reaction segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years.  This is attributed to the detection of infectious diseases such as COVID-19 and others. The growing prevalence of infectious diseases is boosting the global market growth at a significant rate. The high demand for high throughput PCR tests to detect infectious diseases is increasing the popularity of PCR kits and reagents in the global market. Next-generation sequencing is also a very popular technology in the molecular diagnostic market which will further drive the global market growth at a significant rate. Based on application, the global molecular diagnostics market is segmented into Cancer, Blood screening, Infectious diseases, Microbiology, Genetic tests, and Others. Among these, the Infectious diseases segment is expected to have the fastest-growing market during the forecast period. according to Precision Business Insights. This is due to the increasing prevalence of infectious diseases across the world. Based on end users, the global molecular diagnostics market is segmented into Hospitals, Diagnostic Centres, Research institutes, and Others. The Diagnostic Centres segment accounts for the largest share in 2021 and is anticipated to register a significant CAGR in the upcoming years.  

Molecular Diagnostics Market Key Development:
  • In Oct 2022, Roche launched its next-generation portfolio of SARS-CoV-2 rapid antigen tests under the CE Mark for self-test and professional use.
  • In Sept 2022, Eurofins Genoma announced their launch of niPGT-A, a non-invasive, embryo biopsy-free, preimplantation genetic aneuploidy screening test.

Global Molecular Diagnostics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

10.1%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Molecular Diagnostics Market Dynamics

Increase in the prevalence of infectious diseases and various cancers, a rise in demand for personalized medicines, technological advancements in the diagnostic tests, and rise in the preference for biomarker identification tests are anticipated to propel the market growth over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Molecular Diagnostics Market Segmentation

By Product Type
  • Reagents
  • Kits
  • Instruments
  • Software
By Technology
  • Polymerase chain reaction
  • Microarray
  • Next-generation sequencing
  • Isothermal nucleic acid amplification
  • Hybridization
  • Others
By Application
  • Caner
  • Blood screening
  • Infectious diseases
  • Microbiology
  • Genetic tests
  • Others
By End User
  • Hospitals
  • Diagnostic Centres
  • Research institutes
  • Others

Frequently Asked Questions

The molecular diagnostics market size was valued at USD 9,682.4 million in 2022

The molecular diagnostics market key players are: Danaher Corporation (U.S.) Biomerieux (Sofiana s.a.) (France) Beckman Coulter, Inc. (U.S.) Becton, Dickinson and Company (U.S.) Siemens Healthcare GmbH (Germany) Abbott Laboratories (U.S.) Grifols (Spain) Hologic, Inc. (U.S.) Qiagen (U.S.) Alere Inc. (U.S.) Roche Diagnostics (U.S.) DiaSorin S.p.A. (American Standard Companies) (Italy)

The molecular diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Molecular Diagnostics Market Introduction 
2.1.Global Molecular Diagnostics Market  - Taxonomy
2.2.Global Molecular Diagnostics Market  - Definitions
2.2.1.Product Type 
2.2.2.Technology
2.2.3.Application
2.2.4.End User
2.2.5.Region
3. Global Molecular Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Molecular Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Molecular Diagnostics Market  By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Reagents
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Kits
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Instruments
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Software
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Molecular Diagnostics Market  By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Polymerase chain reaction
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Microarray
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Next-generation sequencing
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Isothermal nucleic acid amplification
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Hybridization
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7. Global Molecular Diagnostics Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Caner
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Blood screening
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Infectious diseases
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Microbiology
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Genetic tests
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Others
7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
8. Global Molecular Diagnostics Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospitals
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Centres
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research institutes
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Molecular Diagnostics Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Molecular Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Reagents
10.1.2.Kits
10.1.3.Instruments
10.1.4.Software
10.2.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Polymerase chain reaction
10.2.2.Microarray
10.2.3.Next-generation sequencing
10.2.4.Isothermal nucleic acid amplification
10.2.5.Hybridization
10.2.6.Others
10.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Caner
10.3.2.Blood screening
10.3.3.Infectious diseases
10.3.4.Microbiology
10.3.5.Genetic tests
10.3.6.Others
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals
10.4.2.Diagnostic Centres
10.4.3.Research institutes
10.4.4.Others
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Molecular Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Reagents
11.1.2.Kits
11.1.3.Instruments
11.1.4.Software
11.2.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Polymerase chain reaction
11.2.2.Microarray
11.2.3.Next-generation sequencing
11.2.4.Isothermal nucleic acid amplification
11.2.5.Hybridization
11.2.6.Others
11.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Caner
11.3.2.Blood screening
11.3.3.Infectious diseases
11.3.4.Microbiology
11.3.5.Genetic tests
11.3.6.Others
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals
11.4.2.Diagnostic Centres
11.4.3.Research institutes
11.4.4.Others
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Molecular Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Reagents
12.1.2.Kits
12.1.3.Instruments
12.1.4.Software
12.2.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Polymerase chain reaction
12.2.2.Microarray
12.2.3.Next-generation sequencing
12.2.4.Isothermal nucleic acid amplification
12.2.5.Hybridization
12.2.6.Others
12.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Caner
12.3.2.Blood screening
12.3.3.Infectious diseases
12.3.4.Microbiology
12.3.5.Genetic tests
12.3.6.Others
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals
12.4.2.Diagnostic Centres
12.4.3.Research institutes
12.4.4.Others
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Molecular Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Reagents
13.1.2.Kits
13.1.3.Instruments
13.1.4.Software
13.2.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Polymerase chain reaction
13.2.2.Microarray
13.2.3.Next-generation sequencing
13.2.4.Isothermal nucleic acid amplification
13.2.5.Hybridization
13.2.6.Others
13.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Caner
13.3.2.Blood screening
13.3.3.Infectious diseases
13.3.4.Microbiology
13.3.5.Genetic tests
13.3.6.Others
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals
13.4.2.Diagnostic Centres
13.4.3.Research institutes
13.4.4.Others
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Molecular Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Reagents
14.1.2.Kits
14.1.3.Instruments
14.1.4.Software
14.2.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Polymerase chain reaction
14.2.2.Microarray
14.2.3.Next-generation sequencing
14.2.4.Isothermal nucleic acid amplification
14.2.5.Hybridization
14.2.6.Others
14.3.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Caner
14.3.2.Blood screening
14.3.3.Infectious diseases
14.3.4.Microbiology
14.3.5.Genetic tests
14.3.6.Others
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals
14.4.2.Diagnostic Centres
14.4.3.Research institutes
14.4.4.Others
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Danaher Corporation (U.S)
15.2.2.Biomerieux (Sofiana s.a.) (France)
15.2.3.Beckman Coulter, Inc. (U.S.)
15.2.4.Becton, Dickinson and Company (U.S.)
15.2.5.Siemens Healthcare GmbH (Germany)
15.2.6.Abbott Laboratories (U.S.)
15.2.7.Grifols (Spain)
15.2.8.Hologic, Inc. (U.S.)
15.2.9.Qiagen (U.S.)
15.2.10.Alere Inc. (U.S.)
15.2.11.Roche Diagnostics (U.S.)
15.2.12.DiaSorin S.p.A. (American Standard Companies) (Italy)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Danaher Corporation (U.S)
  • Biomerieux (Sofiana s.a.) (France)
  • Beckman Coulter, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • Abbott Laboratories (U.S.)
  • Grifols (Spain)
  • Hologic, Inc. (U.S.)
  • Qiagen (U.S.)
  • Alere Inc. (U.S.)
  • Roche Diagnostics (U.S.)
  • DiaSorin S.p.A. (American Standard Companies) (Italy)